Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Berglund

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
Poxvirus DNA primaseFrank S De Silva, Whitney Lewis, Peter Berglund, et al.
Vaccine|August 24, 2020
ZVex™, a dendritic-cell-tropic lentivector, primes protective antitumor T cell responses that are significantly boosted using heterologous vaccine modalitiesJardin A Leleux, Tina C Albershardt, Andrea J Parsons, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2014
Common genetic variants in the glucocorticoid receptor and the 11β-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing's syndrome in remissionOskar Ragnarsson, Camilla A M Glad, Peter Berglund, et al.
The Journal of Biological Chemistry|February 3, 2006
Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2Claudia Thilo, Peter Berglund, Steven E Applequist, et al.
Scientific Reports|March 17, 2017
Reduced DNA methylation and psychopathology following endogenous hypercortisolism - a genome-wide studyCamilla A M Glad, Johanna C Andersson-Assarsson, Peter Berglund, et al.
NPJ Vaccines|June 25, 2020
Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumorsTina C Albershardt, Jardin Leleux, Andrea J Parsons, et al.
European Journal of Endocrinology|June 5, 2013
Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remissionOskar Ragnarsson, Peter Berglund, Derek N Eder, et al.
Molecular Therapy Oncolytics|September 15, 2016
LV305, a dendritic cell-targeting integration-deficient ZVex(TM)-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune responseTina Chang Albershardt, David James Campbell, Andrea Jean Parsons, et al.
Nucleic Acids Research|December 21, 2012
Vaccinia and influenza A viruses select rather than adjust tRNAs to optimize translationMariana Pavon-Eternod, Alexandre David, Kimberly Dittmar, et al.
Clinical Neurology and Neurosurgery|January 24, 2017
Key clinical milestones 15 years and onwards after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001Radu Constantinescu, Barbro Eriksson, Yvonne Jansson, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
Poxvirus DNA primaseFrank S De Silva, Whitney Lewis, Peter Berglund, et al.
Vaccine|August 24, 2020
ZVex™, a dendritic-cell-tropic lentivector, primes protective antitumor T cell responses that are significantly boosted using heterologous vaccine modalitiesJardin A Leleux, Tina C Albershardt, Andrea J Parsons, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2014
Common genetic variants in the glucocorticoid receptor and the 11β-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing's syndrome in remissionOskar Ragnarsson, Camilla A M Glad, Peter Berglund, et al.
The Journal of Biological Chemistry|February 3, 2006
Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2Claudia Thilo, Peter Berglund, Steven E Applequist, et al.
Scientific Reports|March 17, 2017
Reduced DNA methylation and psychopathology following endogenous hypercortisolism - a genome-wide studyCamilla A M Glad, Johanna C Andersson-Assarsson, Peter Berglund, et al.
NPJ Vaccines|June 25, 2020
Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumorsTina C Albershardt, Jardin Leleux, Andrea J Parsons, et al.
European Journal of Endocrinology|June 5, 2013
Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remissionOskar Ragnarsson, Peter Berglund, Derek N Eder, et al.
Molecular Therapy Oncolytics|September 15, 2016
LV305, a dendritic cell-targeting integration-deficient ZVex(TM)-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune responseTina Chang Albershardt, David James Campbell, Andrea Jean Parsons, et al.
Nucleic Acids Research|December 21, 2012
Vaccinia and influenza A viruses select rather than adjust tRNAs to optimize translationMariana Pavon-Eternod, Alexandre David, Kimberly Dittmar, et al.
Clinical Neurology and Neurosurgery|January 24, 2017
Key clinical milestones 15 years and onwards after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001Radu Constantinescu, Barbro Eriksson, Yvonne Jansson, et al.
Pageof 5